Abstract
The progressive loss of structure and functions of neurons, including neuronal death, is one of the main factors leading to poor quality of life. Promotion of functional recovery of neuron after injury is a great challenge in neuroregenerative studies. Melatonin, a hormone is secreted by pineal gland and has antioxidative, anti-inflammatory, and anti-apoptotic properties. Besides that, melatonin has high cell permeability and is able to cross the blood–brain barrier. Apart from that, there are no reported side effects associated with long-term usage of melatonin at both physiological and pharmacological doses. Thus, in this review article, we summarize the pharmacological effects of melatonin as neuroprotectant in central nervous system injury, ischemic-reperfusion injury, optic nerve injury, peripheral nerve injury, neurotmesis, axonotmesis, scar formation, cell degeneration, and apoptosis in rodent models.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acuña-Castroviejo D, Coto-Montes A, Gaia Monti M, Ortiz GG, Reiter RJ (1997) Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci 60:PL23–PL29. https://doi.org/10.1016/S0024-3205(96)00606-6
Acuña-Castroviejo D, Escames G, LeÓn J, Carazo A, Khaldy H (2003) Mitochondrial regulation by melatonin and its metabolites. In: Allegri G, Costa CVL, Ragazzi E, Steinhart H, Varesio L (eds) Developments in tryptophan and serotonin metabolism. Springer, Boston, pp 549–557. https://doi.org/10.1007/978-1-4615-0135-0_63
Acuña-Castroviejo D, Escames G, López LC, Hitos AB, León J (2005) Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis. Endocrine 27:159–168. https://doi.org/10.1385/ENDO:27:2:159
Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S (2010) Melatonin MT1 and MT2 receptor expression in Parkinson’s disease. Med Sci Monit 16:BR61–BR67
Agthong S, Kaewsema A, Tanomsridejchai N, Chentanez V (2006) Activation of MAPK ERK in peripheral nerve after injury. BMC Neurosci 7:45–53. https://doi.org/10.1186/1471-2202-7-45
Alghamdi BS (2018) The neuroprotective role of melatonin in neurological disorders. J Neurosci Res 96:1136–1149. https://doi.org/10.1002/jnr.24220
Alluri H, Wilson RL, Anasooya Shaji C, Wiggins-Dohlvik K, Patel S, Liu Y, Peng X, Beeram MR, Davis ML, Huang JH, Tharakan B (2016) Melatonin preserves blood-brain barrier integrity and permeability via matrix metalloproteinase-9 inhibition. PLoS ONE 11:e0154427. https://doi.org/10.1371/journal.pone.0154427
Alonso-Alconada D, Álvarez A, Arteaga O, Martínez-Ibargüen A, Hilario E (2013) Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia. Int J Mol Sci 14:9379–9395. https://doi.org/10.3390/ijms14059379
Alvira D, Tajes M, Verdaguer E, Acuña-Castroviejo D, Folch J, Camins A, Pallas M (2006) Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson’s disease. J Pineal Res 40:251–258. https://doi.org/10.1111/j.1600-079X.2005.00308.x
Andrabi SA, Sayeed I, Siemen D, Wolf G, Horn TFW (2004) Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 18:869–871. https://doi.org/10.1096/fj.03-1031fje
Antolín I, Mayo JC, Sainz RM, del Brío Mde L, Herrera F, Martín V, Rodríguez C (2002) Protective effect of melatonin in a chronic experimental model of Parkinson’s disease. Brain Res 943:163–173. https://doi.org/10.1016/S0006-8993(02)02551-9
Antoniadis G, Kretschmer T, Pedro MT, König RW, Heinen CPG, Richter HP (2014) Iatrogenic nerve injuries: prevalence, diagnosis and treatment. Dtsch Arztebl Int 111:273–279. https://doi.org/10.3238/arztebl.2014.0273
Aranda ML, González Fleitas MF, De Laurentiis A, Keller Sarmiento MI, Chianelli M, Sande PH, Dorfman D, Rosenstein RE (2016) Neuroprotective effect of melatonin in experimental optic neuritis in rats. J Pineal Res 60:360–372. https://doi.org/10.1111/jpi.12318
Atik B, Erkutlu I, Tercan M, Buyukhatipoglu H, Bekerecioglu M, Pence S (2011) The effects of exogenous melatonin on peripheral nerve regeneration and collagen formation in rats. J Surg Res 166:330–336. https://doi.org/10.1016/j.jss.2009.06.002
Babaei-Balderlou F, Zare S, Heidari R, Farrokhi F (2010) Effects of melatonin and vitamin E on peripheral neuropathic pain in streptozotocin-induced diabetic rats. Iran J Basic Med Sci 13:1–8. https://doi.org/10.22038/IJBMS.2010.5074
Baykal A, Iskit AB, Hamaloglu E, Guc MO, Hascelik G, Sayek I (2000) Melatonin modulates mesenteric blood flow and TNFα concentrations after Lipopolysaccharide challenge. Eur J Surg 166:722–727. https://doi.org/10.1080/110241500750008484
Benga A, Zor F, Korkmaz A, Marinescu B, Gorantla V (2017) The neurochemistry of peripheral nerve regeneration. Indian J Plast Surg 50:5–15. https://doi.org/10.4103/ijps.ijps_14_17
Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuña-Castroviejo D, Guerrero JM (1996) Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 20:205–210. https://doi.org/10.1111/j.1600079X.1996.tb00260.x
Bezard E, Imbert C, Gross CE (1998) Experimental models of Parkinson’s disease: from the static to the dynamic. Rev Neurosci 9:71–90
Bilici D, Akpinar E, Kiziltunç A (2002) Protective effect of melatonin in carrageenan-induced acute local inflammation. Pharmacol Res 46:133–139. https://doi.org/10.1016/S1043-6618(02)00089-0
Billingsley ML, Kincaid RL (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323:577–591. https://doi.org/10.1042/bj3230577
Björkqvist SE, Lang AH, Punnonen R, Rauramo L (1977) Carpal Tunnel Syndrome in ovariectomized women. Acta Obstet Gynecol Scand 56:127–130. https://doi.org/10.3109/00016347709158354
Borjigin J, Wang MM, Synder SH (1995) Diurnal variation in mRNA encoding serotonin N-acetyltransferase in pineal gland. Nature 378:783–785. https://doi.org/10.1038/378783a0
Braak F, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567. https://doi.org/10.1007/BF00293315
Brion JP, Anderton BH, Authelet M, Dayanandan R, Leroy K, Lovestone S, Octave JN, Pradier L, Touchet N, Tremp G (2001) Neurofibrillary tangles and tau phosphorylation. Biochem Soc Symp 67:81–88. https://doi.org/10.1042/bss0670081
Britt JM, Kane JR, Spaeth CS, Zuzek A, Robinson GL, Gbanaglo MY, Estler CJ, Boydston EA, Schallert T, Bittner GD (2010) Polyethylene glycol rapidly restores axonal integrity and improves the rate of motor behavior recovery after Sciatic nerve crush injury. J Neurophysiol 104:695–703. https://doi.org/10.1152/jn.01051.2009
Brusco LI, Márquez M, Cardinali DP (2000) Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer’s disease. Neuro Endocrinol Lett 21:39–42
Caplan LR, Leary MC, Thomas AJ, Zhang JH, Biller J, Lo EH, Yenari M (2017) Primer on cerebrovascular diseases. Academic Press, London, pp 901–947
Cardinali DP, Furio AM, Brusco LI (2010) Clinical aspects of melatonin intervention in Alzheimers disease progression. Curr Neuropharmacol 8:218–227. https://doi.org/10.2174/157015910792246209
Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI (2012) Therapeutic application of melatonin in mild cognitive impairment. Am J Neurodegener Dis 3:280–291. https://doi.org/10.3390/antiox3020245
Carlson LL, Weaver DR, Reppert SM (1989) Melatonin signal transduction in hamster brain: inhibition of adenylyl cyclase by a pertussis toxin- sensitive g protein. Endocrinology 125:2670–2676. https://doi.org/10.1210/endo-125-5-2670
Carlsson A (1959) The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev 11:490–493
Carlsson A, Lindqvist M, Magnusson T (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200
Cervantes M, Moralí G, Letechipía-Vallejo G (2008) Melatonin and ischemia-reperfusion injury of the brain. J Pineal Res 45:1–7. https://doi.org/10.1111/j.1600-079X.2007.00551.x
Chandra R, Upadhyaya G, Dass SK, Jain R (2000) Co-administration of melatonin reverses the tin-protoporphyrin (SnPP) induced decline of cytochrome P450 content in vivo in rats. Eur J Drug Metab Pharmacokinet 25:213–218. https://doi.org/10.1007/BF03192316
Chang HM, Ling EA, Lue JH, Wen CY, Shieh JY (2000) Melatonin attenuates neuronal NADPH-d/NOS expression in the hypoglossal nucleus of adult rats following peripheral nerve injury. Brain Res 873:243–251. https://doi.org/10.1016/S0006-8993(00)02489-6
Chen HY, Chen TY, Lee MY, Chen ST, Hsu YS, Kuo YL, Chang GL, Wu TS, Lee EJ (2006) Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 41:175–182. https://doi.org/10.1111/j.1600-079X.2006.00351.x
Chen Q, Xu H, Xu A, Ross T, Bowler E, Hu Y, Lesnefsky EJ (2015) Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria. PLoS One 10:e0118834. https://doi.org/10.1371/journal.pone.0118834
Cheung RT (2003) The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 34:153–160. https://doi.org/10.1034/j.1600-079X.2003.00034.x
Cho S, Joh TH, Baik HH, Dibinis C, Volpe BT (1997) Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats. Brain Res 755:335–338. https://doi.org/10.1016/S0006-8993(97)00188-1
Chuang JI, Mohan N, Meltz ML, Reiter RJ (1996) Effect of melatonin on NF-κB DNA-binding activity in the rat spleen. Cell Biol Int 20:687–692. https://doi.org/10.1006/cbir.1996.0091
Coon SL, Roseboom PH, Baler R, Weller JL, Namboodiri MA, Koonin EV, Klein DC (1995) Pineal serotonin nacetyltransferase: expression cloning and molecular analysis. Science 270:1681–1683. https://doi.org/10.1126/science.270.5242.1681
Cuzzocrea S, Costantino G, Gitto E, Mazzon E, Fulia F, Serraino I, Cordaro S, Barberi I, De Sarro A, Caputi AP (2000) Protective effects of melatonin in ischemic brain injury. J Pineal Res 29:217–227. https://doi.org/10.1034/j.1600-0633.2002.290404.x
Dabbeni-Sala F, Di Santo S, Franceschini D, Skaper SD, Giusti P (2001) Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 15:164–170. https://doi.org/10.1096/fj.00-0129com
De Butte M, Fortin T, Pappas BA (2002) Pinealectomy: behavioral and neuropathological consequences in a chronic cerebral hypoperfusion model. Neurobiol Aging 23:309–317. https://doi.org/10.1016/S0197-4580(01)00277-9
Deng WG, Tang ST, Tseng HP, Wu KK (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108:518–524. https://doi.org/10.1182/blood-2005-09-3691
Deumens R, Bozkurt A, Meek MF, Marcus MA, Joosten EA, Weis J, Brook GA (2010) Repairing injured peripheral nerves: bridging the gap. Prog Neurobiol 92:245–276. https://doi.org/10.1016/j.pneurobio.2010.10.002
Didier N, Romero IA, Créminon C, Wijkhuisen A, Grassi J, Mabondzo A (2003) Secretion of interleukin-1β by astrocytes mediates endothelin-1 and tumour necrosis factor-α effects on human brain microvascular endothelial cell permeability. J Neurochem 86:246–254. https://doi.org/10.1046/j.1471-4159.2003.01829.x
Donnelly PS, Caragounis A, Du T, Laughton KM, Volitakis I, Cherny RA, Sharples RA, Hill AF, Li QX, Masters CL, Barnham KJ, White AR (2008) Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-β peptide. J Biol Chem 283:4568–4577. https://doi.org/10.1074/jbc.M705957200
Dragicevic N, Copes N, O’Neal-Moffitt G, Jin J, Buzzeo R, Mamcarz M, Tan J, Cao C, Olcese JM, Arendash GW, Bradshaw PC (2011) Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 51:75–86. https://doi.org/10.1111/j.1600-079X.2011.00864.x
Drijfhout W, van der Linde A, de Vries J, Grol C, Westerink B (1996) Microdialysis reveals dynamics of coupling between noradrenaline release and melatonin secretion in conscious rats. Neurosci Lett 202:185–188. https://doi.org/10.1016/0304-3940(95)12245-1
Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J (2010) International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 62:343–380. https://doi.org/10.1124/pr.110.002832
Ebadi M, Sharma SK, Ghafourifar P, Brown-Borg H, El ReFaey H (2005) Peroxynitrite in the pathogenesis of Parkinson’s disease and the neuroprotective role of metallothioneins. Methods Enzymol 396:276–298
Ek RO, Zencirci ŞG, Dost T, Birincioglu M, Bilgin MD (2007) Effects of melatonin supplementary on the sciatic nerve conduction velocity in the ovariectomized-aged rat. Neuroendocrinol Lett 28:666–670
Ekmekcioglu C (2006) Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 60:97–108. https://doi.org/10.1016/j.biopha.2006.01.002
Esposito E, Genovese T, Caminiti R, Bramanti P, Meli R, Cuzzocrea S (2008) Melatonin regulates matrix metalloproteinases after taumatic experimental spinal cord injury. J Pineal Res 45:149–156. https://doi.org/10.1111/j.1600-079X.2008.00569.x
Fischer DW, Beggs JL, Kenshalo DL, Shetter AG (1985) Comparative study of microepineurial anastomoses with the use of CO2 laser and suture techniques in rat sciatic nerves: Part 1. Surgical technique, nerve action potentials, and morphological studies. Neurosurgery 17:300–308. https://doi.org/10.1227/00006123-198508000-00009
Garcia-Valenzulela E, Gorczyca W, Darzynkiewicz Z, Sharma SC (1994) Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol 25:431–438. https://doi.org/10.1002/neu.480250408
Gómez M, Esparza JL, Nogués MR, Giralt M, Cabré M, Domingo JL (2005) Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic Biol Med 38:104–111. https://doi.org/10.1016/j.freeradbiomed.2004.10.009
Gooley JJ, Chamberlain K, Smith KA, Khalsa SB, Rajaratnam SM, Van Reen E, Zeitzer JM, Czeisler CA, Lockley SW (2011) Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab 96:E463–E472. https://doi.org/10.1210/jc.2010-2098
Götz J, Bodea LG, Goedert M (2018) Rodent models for Alzheimer disease. Nat Rev Neurosci 19:583–598. https://doi.org/10.1038/s41583-018-0054-8
Grace PA (1994) Ischaemia-reperfusion injury. Br J Surg 81:637–647. https://doi.org/10.1002/bjs.1800810504
Guerrero JM, Reiter RJ, Ortiz GG, Pablos MI, Sewerynek E, Chuang JI (1997) Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones Unguiculatus). J Pineal Res 23:24–31. https://doi.org/10.1111/j.1600-079X.1997.tb00331.x
Guntinas-Lichius O, Irintchev A, Streppel M, Lenzen M, Grosheva M, Wewetzer K, Neiss WF, Angelov DN (2005) Factors limiting motor recovery after facial nerve transection in the rat: combined structural and functional analyses. Eur J Neurosci 21:391–402. https://doi.org/10.1111/j.1460-9568.2005.03877.x
Gunzel D, Yu AS (2013) Claudins and the modulation of tight junction permeability. Physiol Rev 93:525–569. https://doi.org/10.1152/physrev.00019.2012
Han F, Tao RR, Zhang GS, Lu YM, Liu LL, Chen YX, Lou YJ, Fukunaga K, Hong ZH (2011) Melatonin ameliorates ischemic-like injury-evoked nitrosative stress: involvement of HtrA2/PED pathways in endothelial cells. J Pineal Res 50:281–291. https://doi.org/10.1111/j.1600-079X.2010.00838.x
Hardeland R (1997) Melatonin: multiple functions in signaling and protection. In: Altmeyer P, Hoffmann K, Stücker M (eds) Skin cancer and UV radiation. Springer, Berlin, pp 186–198
Hardeland R (2013) Chronobiology of melatonin beyond the feedback to the suprachiasmatic nucleus-consequences to melatonin dysfunction. Int J Mol Sci 14:5817–5841. https://doi.org/10.3390/ijms14035817
Hardeland R, Pandi-Perumal SR (2005) Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr Metab (Lond) 2:22. https://doi.org/10.1186/1743-7075-2-22
Hardeland R, Poeggeler B, Niebergall R, Zelosko V (2003) Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J Pineal Res 34:17–25. https://doi.org/10.1034/j.1600-079X.2003.02941.x
Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185. https://doi.org/10.1126/science.1566067
Hattar S, Liao HW, Takao M, Berson DM, Yau KW (2002) Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 295:1065–1070. https://doi.org/10.1126/science.1069609
Heckenkamp J, Aleksic M, Gawenda M, Breuer S, Brabender J, Mahdavi A, Aydin F, Brunkwall JS (2004) Modulation of human adventitial fibroblast function by photodynamic therapy of collagen matrix. Eur J Vasc Endovasc Surg 28:651–659. https://doi.org/10.1016/j.ejvs.2004.08.013
Hermes M, Coderre E, Buijs R, Renaud L (1996) GABA and glutamate mediate rapid neurotransmission from suprachiasmatic nucleus to hypothalamic paraventricular nucleus in rat. J Physiol 496:749–757. https://doi.org/10.1113/jphysiol.1996.sp021724
Hilario E, Alvarez A, Alvarez FJ, Gastiasoro E, Valls-i-Soler A (2006) Cellular mechanisms in perinatal hypoxic-ischemic brain injury. Curr Pediatr Rev 2:131–141. https://doi.org/10.2174/157339606776894667
Hogan MV, El-Sherif Y, Wieraszko A (2001) The modulation of neuronal activity by melatonin: in vitro studies on mouse hippocampal slices. J Pineal Res 30:87–96. https://doi.org/10.1034/j.1600-079x.2001.300204.x
Holmes W, Young JZ (1942) Nerve regeneration after immediate and delayed suture. J Anat 77:63–96. https://doi.org/10.1093/oxfordjournals.bmb.a070225
Huang JY, Hong YT, Chuang JI (2009) Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro. J Neurochem 109:1400–1412. https://doi.org/10.1111/j.1471-4159.2009.06061.x
Hulbert AJ, Pamplona R, Buffenstein R, Buttemer WA (2007) Life and death: metabolic rate, membrane composition, and life span of animals. Physiol Rev 87:1175–1213. https://doi.org/10.1152/physrev.00047.2006
Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132–139. https://doi.org/10.1016/S0166-2236(96)10074-6
Idowu AJ, Kumar SL, Yidong B, Russel R (2017) Melatonin modulates neuronal mitochondria function during normal ageing in mice. Niger J Physiol Sci 32:145–152
Ilijic E, Guzman JN, Surmeier DJ (2011) The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson’s disease. Neurobiol Dis 43:364–371. https://doi.org/10.1016/j.nbd.2011.04.007
Itzhak Y, Martin JL, Dean Black M, Ali SF (1998) Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine- induced behavioral sensitization. Neuropharmacology 37:781–791. https://doi.org/10.1016/S0028-3908(98)00067-7
Jockers R, Maurice P, Boutin JA, Delagrange P (2008) Melatonin receptors, heterodimerization, signal transduction and binding sites: what’s new? Br J Pharmacol 154:1182–1195. https://doi.org/10.1038/bjp.2008.184
Joo WS, Jin BK, Park CW, Maeng SH, Kim YS (1998a) Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats. NeuroReport 9:4123–4126. https://doi.org/10.1097/00001756-199812210-00022
Joo JY, Uz T, Manev H (1998b) Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat. Restor Neurol Neurosci 13:185–191
Kaewsuk S, Sae-ung K, Phansuwan-Pujito P, Govitrapong P (2009) Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain. Neurochem Int 55:397–405. https://doi.org/10.1016/j.neuint.2009.04.010
Kalsbeek A, Cutrera R, van Heerikhuize J, van der Vliet J, Buijs R (1999) GABA release from suprachiasmatic nucleus terminals is necessary for the light-induced inhibition of nocturnal melatonin release in the rat. Neuroscience 91:453–461. https://doi.org/10.1016/s0306-4522(98)00635-6
Kaur C, Sivakumar V, Lu J, Tang FR, Ling EA (2008) Melatonin attenuates hypoxia-induced ultrastructural changes and increased vascular permeability in the developing hippocampus. Brain Pathol 18:533–547. https://doi.org/10.1111/j.1750-3639.2008.00156.x
Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH (1993) Smoking cessation and decreased risk of stroke in women. JAMA 269:232–236. https://doi.org/10.1001/jama.1993.03500020066033
Kaya Y, Sarikcioǧlu L, Aslan M, Kencebay C, Demir N, Derin N, Angelov DN, Yildirim FB (2013) Comparison of the beneficial effect of melatonin on recovery after cut and crush sciatic nerve injury: a combined study using functional, electrophysiological, biochemical, and electron microscopic analyses. Child’s Nerv Syst 29:389–401. https://doi.org/10.1007/s00381-012-1936-0
Kebabian J, Zatz M, Romero J, Axelrod J (1975) Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase. Proc Natl Acad Sci USA 72:3735–3739. https://doi.org/10.1073/pnas.72.9.3735
Kermer P, Klöcker N, Labes M, Bähr M (1998) Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J Neurosci 18:4656–4662. https://doi.org/10.1111/j.1467-9957.2004.00403.x
Khodabandehloo F, Hosseini M, Rajaei Z, Soukhtanloo M, Farrokhi E, Rezaeipour M (2013) Brain tissue oxidative damage as a possible mechanism for the deleterious effect of a chronic high dose of estradiol on learning and memory in ovariectomized rats. Arq Neuropsiquiatr 71:313–319. https://doi.org/10.1590/0004-282X20130027
Kilic E, Özdemir YG, Bolay H, Keleştimur H, Dalkara T (1999) Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 19:511–516. https://doi.org/10.1097/00004647-199905000-00005
Kilic E, Hermann DM, Isenmann S, Bähr M (2002) Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection in mice. J Pineal Res 32:106–111. https://doi.org/10.1034/j.1600-079x.2002.1823.x
Kilic U, Yilmaz B, Ugur M, Yüksel A, Reiter RJ, Hermann DM, Kilic E (2012) Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 52:228–235. https://doi.org/10.1111/j.1600-079X.2011.00932.x
Koh PO (2008) Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3. J Pineal Res 44:101–106. https://doi.org/10.1111/j.1600-079X.2007.00495.x
Lee EJ, Wu TS, Lee MY, Chen TY, Tsai YY, Chuang JI, Chang GL (2004) Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats. J Pineal Res 36:33–42. https://doi.org/10.1046/j.1600-079X.2003.00093.x
Lee CH, Yoo KY, Choi JH, Park OK, Hwang IK, Kwon YG, Kim YM, Won MH (2010) Melatonin’s protective action against ischemic neuronal damage is associated with up-regulation of the MT2 melatonin receptor. J Neurosci Res 88:2630–2640. https://doi.org/10.1002/jnr.22430
León J, Macías M, Escames G, Camacho E, Khaldy H, Martín M, Espinosa A, Gallo MA, Acuña-Castroviejo D (2000) Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines. Mol Pharmacol 58:967–975. https://doi.org/10.1124/mol.58.5.967
León J, Escames G, Rodríguez MI, López LC, Tapias V, Entrena A, Camacho E, Carrión MD, Gallo MA, Espinosa A, Tan DX, Reiter RJ, Acuña-Castroviejo D (2006) Inhibition of neuronal nitric oxide synthase activity by N 1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 98:2023–2033. https://doi.org/10.1111/j.1471-4159.2006.04029.x
Liang K, Ye Y, Wang Y, Zhang J, Li C (2014) Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3 K/Akt signaling pathway. J Neurol Sci 344:100–104. https://doi.org/10.1016/j.jns.2014.06.033
Lin CH, Huang JY, Ching CH, Chuang JI (2008) Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats. J Pineal Res 44:205–213. https://doi.org/10.1111/j.1600-079X.2007.00510.x
Lin L, Huang Q, Yang S, Chu J, Wang J (2013) Melatonin in Alzheimer’ s disease. Int J Mol Sci 14:14575–14593. https://doi.org/10.3390/ijms140714575
Ling X, Zhang LM, Lu SD, Li XJ, Sun FY (1999) Protective effect of melatonin on injuried cerebral neurons is associated with bcl-2 protein over-expression. Zhongguo Yao Li Xue Bao 20:409–414
Ling ZQ, Tian Q, Wang L, Fu ZQ, Wang XC, Wang Q, Wang JZ (2009) Constant illumination induces Alzheimer-like damages with endoplasmic reticulum involvement and the protection of melatonin. J Alzheimer’s Dis 16:287–300. https://doi.org/10.3233/JAD-2009-0949
Liu K, Agre P (2013) Aquaporin water channels. In: Lennarz WJ, Lane MD (eds) Encyclopedia of biological chemistry, 2nd edn, pp 120–126. https://doi.org/10.1016/B978-0-12-378630-2.00055-4
Liu F, Ng TB (2000) Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. Biochem Cell Biol 78:447–453
Liu SJ, Wang JZ (2002) Alzheimer-like tau phosphorylation induced by wortmannin in vivo and its attenuation by melatonin. Acta Pharmacol Sin 23:183–187
Liu D, Wei N, Man HY, Lu Y, Zhu LQ, Wang JZ (2015) The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling. Cell Death Differ 22:583–596. https://doi.org/10.1038/cdd.2014.195
Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M, Canesi L, Papa S, Galli F (2010) Melatonin signaling and cell protection function. FASEB J 24:3603–3624. https://doi.org/10.1096/fj.10-154450
Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer’s disease. J Neurochem 68:2061–2069. https://doi.org/10.1046/j.1471-4159.1997.68052061.x
Ma J, Shaw VE, Mitrofanis J (2009) Does melatonin help save dopaminergic cells in MPTP-treated mice? Parkinsonism Relat Disord 15:307–314. https://doi.org/10.1016/j.parkreldis.2008.07.008
Mack JM, Schamne MG, Sampaio TB, Pértile RA, Fernandes PA, Markus RP, Prediger RD (2016) Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms. Oxid Med Cell Longev 2016:3472032. https://doi.org/10.1155/2016/3472032
MacMahon S, Rodgers A (1994) The epidemiological association between blood pressure and stroke: implications for primary and secondary prevention. Hypertens Res 17:S23–S32. https://doi.org/10.1291/hypres.17.SupplementI_S23
Maguire-Zeiss KA, Federoff HJ (2010) Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease. J Neural Transm 117:1019–1025. https://doi.org/10.1007/s00702-010-0431-6
Manev H, Uz T, Kharlamov A, Joo JY (1996) Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J 10:1546–1551. https://doi.org/10.1096/fasebj.10.13.8940301
Manev H, Uz T, Qu T (1998) Early upregulation of hippocampal 5-lipoxygenase following systemic administration of kainate to rats. Restor Neurol Neurosci 12:81–85
Martín M, Macías M, León J, Escames G, Khaldy H, Acuña-Castroviejo D (2002) Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 34:348–357. https://doi.org/10.1016/S1357-2725(01)00138-8
Matsubara E, Bryant-thomas T, Pacheco Quinto J, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA, Chain DG, Neria E (2003) Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease. J Neurochem 85:1101–1108. https://doi.org/10.1046/j.1471-4159.2003.01654.x
Matuszak Z, Bilska MA, Reszka KJ, Chignell CF, Bilski P (2003) Interaction of singlet molecular oxygen with melatonin and related indoles. Photochem Photobiol 78:449–455. https://doi.org/10.1562/0031-8655(2003)078%3c0449:IOSMOW%3e2.0.CO;2
Mayo JC, Sainz RM, Tan DX, Antolín I, Rodríguez C, Reiter RJ (2005a) Melatonin and Parkinson’s disease. Endocrine 27:169–178
Mayo JC, Sainz RM, Tan DX, Hardeland R, Leon J, Rodriguez C, Reiter RJ (2005b) Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 165:139–149. https://doi.org/10.1016/j.jneuroim.2005.05.002
Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36:747–751. https://doi.org/10.1002/ana.410360510
Mekaj AY, Morina AA, Bytyqi CI, Mekaj YH, Duci SB (2014) Application of topical pharmacological agents at the site of peripheral nerve injury and methods used for evaluating the success of the regenerative process. J Orthop Surg Res 9:94. https://doi.org/10.1186/s13018-014-0094-3
Mizuno Y, Sone N, Saitoh T (1987) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem 48:1787–1793
Monteiro SC, Matté C, Bavaresco CS, Netto CA, Wyse ATS (2005) Vitamins E and C pretreatment prevents ovariectomy-induced memory deficits in water maze. Neurobiol Learn Mem 84:192–199. https://doi.org/10.1016/j.nlm.2005.08.002
Mukda S, Vimolratana O, Govitrapong P (2011) Melatonin attenuates the amphetamine-induced decrease in vesicular monoamine transporter-2 expression in postnatal rat striatum. Neurosci Lett 488:154–157. https://doi.org/10.1016/j.neulet.2010.11.019
Mullaart E, Boerrigter METI, Ravid R, Swaab DF, Vijg J (1990) Increased levels of DNA breaks in cerebral cortex of Alzheimer’s disease patients. Neurobiol Aging 11:169–173. https://doi.org/10.1016/0197-4580(90)90542-8
Nagai R, Watanabe K, Wakatsuki A, Hamada F, Shinohara K, Hayashi Y, Imamura R, Fukaya T (2008) Melatonin preserves fetal growth in rats by protecting against ischemia/reperfusion-induced oxidative/nitrosative mitochondrial damage in the placenta. J Pineal Res 45:271–276. https://doi.org/10.1111/j.1600-079X.2008.00586.x
Naseem M, Parvez S (2014) Role of melatonin in traumatic brain injury and spinal cord injury. Sci World J 2014:586270. https://doi.org/10.1155/2014/586270
Navarro X (2015) Functional evaluation of peripheral nerve regeneration and target reinnervation in animal models: a critical overview. Eur J Neurosci 43:271–286. https://doi.org/10.1111/ejn.13033
Ng KY, Leong MK, Liang H, Paxinos G (2017) Melatonin receptors: distribution in mammalian brain and their respective putative functions. Brain Struct Funct 222:2921–2939. https://doi.org/10.1007/s00429-017-1439-6
Nicklas W, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine. Life Sci 36(26):2503–2508. https://doi.org/10.1016/0024-3205(85)90146
Niranjan R, Nath C, Shukla R (2010) The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6. Free Radic Res 44:1304–1316. https://doi.org/10.3109/10715762.2010.501080
Nukada H, Powell HC, Myers RR (1993) Spatial distribution of nerve injury after occlusion of individual major vessels in rat sciatic nerves. J Neuropathol Exp Neurol 52:452–459. https://doi.org/10.1097/00005072-199309000-00003
Odaci E, Kaplan S (2009) Melatonin and nerve regeneration. Int Rev Neurobiol 87:317–335. https://doi.org/10.1016/S0074-7742(09)87016-5
O’Neal-Moffitt G, Pilli J, Kumar SS, Olcese J (2014) Genetic deletion of MT1/MT2 melatonin receptors enhances murine cognitive and motor performance. Neuroscience 277:506–521. https://doi.org/10.1016/j.neuroscience.2014.07.018
Park SW, Lee HS, Sung MS, Kim SJ (2012) The effect of melatonin on retinal ganglion cell survival in ischemic retina. Chonnam Med J 48:116–122. https://doi.org/10.1111/j.1600-079X.2009.00678.x
Pascual E, Giner V, Aróstegui A, Conill J, Ruiz MT, Picó A (1991) Higher incidence of carpal tunnel syndrome in oophorectomized women. Br J Rheumatol 30:60–62. https://doi.org/10.1093/rheumatology/30.1.60
Pei Z, Pang SF, Cheung RT (2002) Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 32:168–172. https://doi.org/10.1034/j.1600-079x.2002.1o847.x
Pei Z, Pang SF, Cheung RT (2003) Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke 34:770–775. https://doi.org/10.1161/01.STR.0000057460.14810.3E
Perianayagam MC, Oxenkrug GF, Jaber BL (2005) Immune-modulating effects of melatonin, N-acetylserotonin, and N-acetyldopamine. Ann N Y Acad Sci 1053:386–393
Perreau-Lenz S, Kalsbeek A, Pévet P, Buijs R (2004) Glutamatergic clock output stimulates melatonin synthesis at night. Eur J Neurosci 19:318–324. https://doi.org/10.1111/j.0953-816x.2003.03132.x
Peschke E, Mühlbauer E, Mußhoff U, Csernus VJ, Chankiewitz E, Peschke D (2002) Receptor (MT1) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 33:63–71. https://doi.org/10.1034/j.1600-079X.2002.02919.x
Petit L, Lacroix I, De Coppet P, Strosberg AD, Jockers R (1999) Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3′-5′-monophosphate pathway. Biochem Pharmacol 58:633–639. https://doi.org/10.1016/S0006-2952(99)00134-3
Petrosillo G, Moro N, Ruggiero FM, Paradies G (2009) Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic Biol Med 47:969–974. https://doi.org/10.1016/j.freeradbiomed.2009.06.032
Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76:1265–1274
Qian Y, Han Q, Zhao X, Song J, Cheng Y, Fang Z, Ouyang Y, Yuan WE, Fan C (2018) 3D melatonin nerve scaffold reduces oxidative stress and inflammation and increases autophagy in peripheral nerve regeneration. J Pineal Res 65:e12516. https://doi.org/10.1111/jpj.12516
Reiter RJ (1995a) The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage. Neurochem Int 27:453–460. https://doi.org/10.1016/0197-0186(95)80002-3
Reiter RJ (1995b) The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol 30:199–212. https://doi.org/10.1016/0531-5565(94)00045-5
Reiter RJ (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56:359–384. https://doi.org/10.1016/S0301-0082(98)00052-5
Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD, Saarela S (1994) Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann N Y Acad Sci 719:1–12. https://doi.org/10.1111/j.1749-6632.1994.tb56817.x
Reiter R, Tang L, Garcia JJ, Muñoz-Hoyos A (1997) Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 60:2255–2271. https://doi.org/10.1016/S0024-3205(97)00030-1
Reiter RJ, Garcia JJ, Pie J (1998) Oxidative toxicity in models of neurodegeneration: responses to melatonin. Restor Neurol Neurosci 12:135–142
Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S (2001) Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci 939:200–215. https://doi.org/10.1111/j.1749-6632.2001.tb03627.x
Reiter RJ, Tan DX, Leon J, Kilic Ü, Kilic E (2005) When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med 230:104–117. https://doi.org/10.1177/153537020523000205
Rivera-Bermúdez MA, Masana MI, Brown GM, Earnest DJ, Dubocovich ML (2004) Immortalized cells from the rat suprachiasmatic nucleus express functional melatonin receptors. Brain Res 1002:21–27. https://doi.org/10.1016/j.brainres.2003.12.008
Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, Reiter RJ (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36:1–9
Rogério F, de Souza Queiroz L, Teixeira SA, Oliveira AL, de Nucci G, Langone F (2002) Neuroprotective action of melatonin on neonatal rat motoneurons after sciatic nerve transection. Brain Res 926:33–41. https://doi.org/10.1016/S0006-8993(01)03286-3
Roseboom PH, Coon SL, Baler R, Mccune SK, Weller JL, Klein DC (1996) Melatonin synthesis: analysis of the more than 150-fold nocturnal increase in serotonin N-acetyltrasferase messenger ribonucleic acid in the rat pineal gland. Endocrinology 137:3033–3044. https://doi.org/10.1210/en.137.7.3033
Samantaray S, Das A, Thakore NP, Matzelle DD, Reiter RJ, Ray SK, Banik NL (2009) Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res 47:134–142. https://doi.org/10.1111/j.1600-079X.2009.00703.x
Saravanan KS, Sindhu KM, Mohanakumar KP (2007) Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J Pineal Res 42:247–253. https://doi.org/10.1111/j.1600-079X.2006.00412.x
Savaskan E, Olivieri G, Meier F, Brydon L, Jockers R, Ravid R, Wirz-Justice A, Müller-Spahn F (2002) Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer’s disease patients. J Pineal Res 32:59–62. https://doi.org/10.1034/j.1600-079x.2002.00841.x
Savaskan E, Ayoub MA, Ravid R, Angeloni D, Fraschini F, Meier F, Eckert A, Müller-Spahn F, Jockers R (2005) Reduced hippocampal MT2melatonin receptor expression in Alzheimer’s disease. J Pineal Res 38:10–16. https://doi.org/10.1111/j.1600-079X.2004.00169.x
Sayan H, Ozacmak VH, Ozen OA, Coskun O, Arslan SO, Sezen SC, Aktas RG (2004) Beneficial effects of melatonin on reperfusion injury in rat sciatic nerve. J Pineal Res 37:143–148. https://doi.org/10.1111/j.1600-079X.2004.00145.x
Seo TB, Oh MJ, You BG, Kwon KB, Chang IA, Yoon JH, Lee CY, Namgung U (2009) ERK1/2-mediated Schwann cell proliferation in the regenerating sciatic nerve by treadmill training. J Neurotrauma 26:1733–1744. https://doi.org/10.1089/neu.2008.0711
Sharkey J, Olcese J (2007) Transcriptional inhibition of oxytocin receptor expression in human myometrial cells by melatonin involves protein kinase C signaling. J Clin Endocrinol Metab 92:4015–4019. https://doi.org/10.1210/jc.2007-1128
Sheu JY, Kulhanek DJ, Eckenstein FP (2000) Differential patterns of ERK and STAT3 phosphorylation after sciatic nerve transection in the rat. Exp Neurol 166:392–402. https://doi.org/10.1006/exnr.2000.7508
Shukla M, Govitrapong P, Boontem P, Reiter RJ, Satayavivad J (2017) Mechanisms of melatonin in alleviating Alzheimer’s disease. Curr Neuropharmacol 15:1010–1031. https://doi.org/10.2174/1570159X15666170313123454
Signorelli SS, Neri S, Sciacchitano S, Di Pino L, Costa MP, Marchese G, Celotta G, Cassibba N, Pennisi G, Caschetto S (2006) Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53:77–82. https://doi.org/10.1016/j.maturitas.2005.03.001
Simi A, Tsakiri N, Wang P, Rothwell NJ (2007) Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 35:1122–1126. https://doi.org/10.1042/BST0351122
Singhal NK, Srivastava G, Agrawal S, Jain SK, Singh MP (2012) Melatonin as a neuroprotective agent in the rodent models of Parkinson’s disease: is it all set to irrefutable clinical translation? Mol Neurobiol 45:186–199. https://doi.org/10.1007/s12035-011-8225-x
Singhanat K, Apaijai N, Chattipakorn SC, Chattipakorn N (2018) Roles of melatonin and its receptors in cardiac ischemia-reperfusion injury. Cell Mol Life Sci 75:4125–4149. https://doi.org/10.1007/s00018-018-2905-x
Sinha K, Degaonkar MN, Jagannathan NR, Gupta YK (2001) Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats. Eur J Pharmacol 428:185–192. https://doi.org/10.1016/S0014-2999(01)01253-5
Siu AW, Ortiz GG, Benitez-King G, To CH, Reiter RJ (2004) Effect of melatonin on the nitric oxide treated retina. Br J Ophthalmol 88:1078–1081. https://doi.org/10.1136/bjo.2003.037879
Srinivasan V, Pandi-Perumal SR, Maestroni GJM, Esquifino AI, Hardeland R, Cardinali DP (2005) Role of melatonin in neurodegenerative diseases. Neurotox Res 7:293–318. https://doi.org/10.1007/BF03033887
Srinivasan V, Cardinali DP, Srinivasan US, Kaur C, Brown GM, Spence DW, Hardeland R, Pandi-Perumal SR (2011) Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection. Ther Adv Neurol Disord 4:297–317. https://doi.org/10.1177/1756285611406166
Stavisky RC, Britt JM, Zuzek A, Truong E, Bittner GD (2005) Melatonin enhances the in vitro and in vivo repair of severed rat sciatic axons. Neurosci Lett 376:98–101. https://doi.org/10.1016/j.neulet.2004.11.033
Sun FY, Lin X, Mao LZ, Ge WH, Zhang LM, Huang YL, Gu J (2002) Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res 33:48–56. https://doi.org/10.1034/j.1600-079X.2002.01891.x
Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T, Takahashi R (2004) Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ 11:208–216. https://doi.org/10.1038/sj.cdd.4401343
Tan DX, Hardeland R, Manchester LC, Poeggeler B, Lopez-Burillo S, Mayo JC, Sainz RM, Reiter RJ (2003) Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 34:249–259. https://doi.org/10.1034/j.1600-079X.2003.00037.x
Tang Q, Hu Y, Cao Y (2006) Neuroprotective effect of melatonin on retinal ganglion cells in rats. J Huazhong Univ Sci Technol Med Sci 26:235–237. https://doi.org/10.1016/j.ejps.2011.05.011
Tansey MG, McCoy MK, Frank-Cannon TC (2007) Neuroinflammatory mechanisms in Parkinson’s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 208:1–25. https://doi.org/10.1016/j.expneurol.2007.07.004
Tao RR, Ji YL, Lu YM, Fukunaga K, Han F (2012) Targeting nitrosative stress for neurovascular protection: new implications in brain diseases. Curr Drug Targets 13:272–284. https://doi.org/10.2174/138945012799201649
Tapias V, Escames G, López LC, López A, Camacho E, Carrión MD, Entrena A, Gallo MA, Espinosa A, Acuña-Castroviejo D (2009) Melatonin and its brain metabolite N1-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in Parkinsonian mice. J Neurosci Res 87:3002–3010. https://doi.org/10.1002/jnr.22123
Tarocco A, Caroccia N, Morciano G, Wieckowski MR, Ancora G, Garani G, Pinton P (2019) Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care. Cell Death Dis 10:317. https://doi.org/10.1038/s41419-019-1556-7
Tesco G, Koh YH, Kang EL, Cameron AN, Das S, Sena-Esteves M, Hiltunen M, Yang SH, Zhong Z, Shen Y, Simpkins JW, Tanzi RE (2007) Depletion of GGA3 stabilizes BACE and enhances β-Secretase activity. Neuron 54:721–737. https://doi.org/10.1016/j.neuron.2007.05.012
Thomas B, Mohanakumar KP (2004) Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. J Pineal Res 36:25–32. https://doi.org/10.1046/j.1600-079X.2003.00096.x
Tomás-Zapico C, Coto-Montes A, Martínez-Fraga J, Rodríguez-Colunga MJ, Hardeland R, Tolivia D (2002) Effects of δ-aminolevulinic acid and melatonin in the Harderian gland of female Syrian hamster. Free Radic Biol Med 32:1197–1204. https://doi.org/10.1016/S0891-5849(02)00812-2
Tosini G, Owino S, Guillaume JL, Jockers R (2014) Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease. BioEssays 36:778–787. https://doi.org/10.1002/bies.201400017
Turgut M, Uyanikgil Y, Baka M, Tunç AT, Yavaşoǧlu A, Yurtseven ME, Kaplan S (2005a) Pinealectomy exaggerates and melatonin treatment suppresses neuroma formation of transected sciatic nerve in rats: gross morphological, histological and stereological analysis. J Pineal Res 38:284–291. https://doi.org/10.1111/j.1600-079X.2004.00205.x
Turgut M, Uysal A, Pehlivan M, Öktem G, Yurtseven ME (2005b) Assessment of effects of pinealectomy and exogenous melatonin administration on rat sciatic nerve suture repair: an electrophysiological, electron microscopic, and immunohistochemical study. Acta Neurochir (Wien) 147:67–77. https://doi.org/10.1007/s00701-004-0426-x
Turgut M, Oktem G, Uysal A, Yurtseven ME (2006a) Immunohistochemical profile of transforming growth factor-beta1 and basic fibroblast growth factor in sciatic nerve anastomosis following pinealectomy and exogenous melatonin administration in rats. J Clin Neurosci 13:753–758. https://doi.org/10.1016/j.jocn.2005.07.019
Turgut M, Uyanikgil Y, Ateş U, Baka M, Yurtseven ME (2006b) Pinealectomy stimulates and exogenous melatonin inhibits harmful effects of epileptiform activity during pregnancy in the hippocampus of newborn rats: an immunohistochemical study. Child’s Nerv Syst 22:481–488. https://doi.org/10.1007/s00381-005-0012-4
Uyanikgil Y, Cavusoglu T, Kilic KD, Yigitturk G, Celik S, Tubbs RS, Turgut M (2017) Useful effects of melatonin in peripheral nerve injury and development of the nervous system. J Brachial Plex PeripherNerve Inj 12:e1–e6. https://doi.org/10.1055/s-0036-1597838
Uz T, Manev H (1998) Circadian expression of pineal 5-lipoxygenase mRNA. Neuroreport 9:783–786. https://doi.org/10.1097/00001756-199803300-00003
Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, Pandey GN, Manev H (2005) The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Mol Brain Res 136:45–53. https://doi.org/10.1016/j.molbrainres.2005.01.002
Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC (2014) Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 71:463–469. https://doi.org/10.1001/jamaneurol.2013.6239
Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA (2005a) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease. J Neurochem 93:953–962. https://doi.org/10.1111/j.1471-4159.2005.03053.x
Wang LM, Suthana NA, Chaudhury D, Weaver DR, Colwell CS (2005b) Melatonin inhibits hippocampal long-term potentiation. Eur J Neurosci 22:2231–2237. https://doi.org/10.1111/j.1460-9568.2005.04408.x
Wang XC, Zhang J, Yu X, Han L, Zhou ZT, Zhang Y, Wang JZ (2005c) Prevention of isoproterenol-induced tau hyperphosphorylation by melatonin in the rat. Sheng Li Xue Bao 57:7–12
Wang X, Figueroa BE, Stavrovskaya IG, Zhang Y, Sirianni AC, Zhu S, Day AL, Kristal BS, Friedlander RM (2009) Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury. Stroke 40:1877–1885. https://doi.org/10.1161/STROKEAHA.108.540765
Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G (2012) Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379:2364–2372. https://doi.org/10.1016/S0140-6736(12)60738-7
Waseem M, Tabassum H, Parvez S (2016) Melatonin modulates permeability transition pore and 5-hydroxydecanoate induced KATP channel inhibition in isolated brain mitochondria. Mitochondrion 31:1–8. https://doi.org/10.1016/j.mito.2016.08.005
Wei J, Ma LS, Liu DJ, Guo J, Jiang WK, Yu HJ (2017) Melatonin regulates traumatic optic neuropathy via targeting autophagy. Eur Rev Med Pharmacol Sci 21:4946–4951
Wei N, Pu Y, Yang Z, Pan Y, Liu L (2019) Therapeutic effects of melatonin on cerebral ischemia reperfusion injury: role of Yap-OPA1 signalling pathway and mitochondrial fusion. Biomed Pharmacother 110:203–212. https://doi.org/10.1016/j.biopha.2018.11.060
Weidemann A, Johnson RS (2008) Biology of HIF-1α. Cell Death Differ 15:621–627. https://doi.org/10.1038/cdd.2008.12
Weissbach H, Redfield BG, Axelrod J (1960) Biosynthesis of melatonin: enzymic conversion of serotonin to N-acetylserotonin. Biochim Biophys Acta 43:352–353. https://doi.org/10.1016/0006-3002(60)90453-4
Witt-Enderby PA, Bennett J, Jarzynka MJ, Firestine S, Melan MA (2003) Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci 72:2183–2198. https://doi.org/10.1016/S0024-3205(03)00098-5
Wu YH, Swaab DF (2005) The human pineal gland and melatonin in aging and Alzheimer’s disease. J. Pineal Res 38:145–152
Wu YH, Feenstra MGP, Zhou JN, Liu RY, Toranõ JS, Van Kan HJM, Fischer DF, Ravid R, Swaab DF (2003) Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab 88:5898–5906. https://doi.org/10.1210/jc.2003-030833
Xiao H, Gu Z, Wang G, Zhao T (2013) The possible mechanisms underlying the impairment of hif-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapies. Int J Med Sci 10:1412–1421. https://doi.org/10.7150/ijms.5630
Xu LX, Lv Y, Li YH, Ding X, Wang Y, Han X, Liu MH, Sun B, Feng X (2017) Melatonin alleviates brain and peripheral tissue edema in a neonatal rat model of hypoxic-ischemic brain damage: the involvement of edema related proteins. BMC Pediatr 17:90–103. https://doi.org/10.1186/s12887-017-0824-x
Yang X, Yang Y, Fu Z, Li Y, Feng J, Luo J, Zhang Q, Wang Q, Tian Q (2011) Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A. J Psychopharmacol 25:1118–1125. https://doi.org/10.1177/026988111036772
Yang L, Yao M, Lan Y, Mo W, Sun YL, Wang J, Wang YJ, Cui XJ (2016) Melatonin for spinal cord injury in animal models: a systematic review and network meta-analysis. J Neurotrauma 33:290–300. https://doi.org/10.1089/neu.2015.4038
Zencirci SG, Bilgin MD, Yaraneri H (2010) Electrophysiological and theoretical analysis of melatonin in peripheral nerve crush injury. J Neurosci Methods 191:277–282. https://doi.org/10.1016/j.jneumeth.2010.07.008
Zhang H, Akbar M, Kim H-Y (1999) Melatonin: an endogenous negative modulator of 12-lipoxygenation in the rat pineal gland. Biochem J 344:487–493. https://doi.org/10.1042/bj3440487
Zhang Y, Zhou H, Wu W, Shi C, Hu S, Yin T, Ma Q, Han T, Zhang Y, Tian F, Chen Y (2016) Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the surpression of the SR-Ca2+-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways. Free Radic Biol Med 95:278–292. https://doi.org/10.1016/j.freeadbiomed.2016.03.035
Zou MH, Shi C, Cohen RA (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109:817–826. https://doi.org/10.1172/JCI0214442
Author information
Authors and Affiliations
Contributions
HYT wrote the manuscript, and KYN and RYK critically reviewed the manuscript. SMC formulated the entire concept and reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.
Research Involving Human Participants or Animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tan, H.Y., Ng, K.Y., Koh, R.Y. et al. Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence. Cell Mol Neurobiol 40, 25–51 (2020). https://doi.org/10.1007/s10571-019-00724-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-019-00724-1